Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Vaxcyte, Inc. (PCVX) had Operating Cash Flow per Share of $-3.71 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-463.93M |
|
-- |
|
-- |
|
$569.55M |
|
$-569.55M |
|
$105.62M |
|
$-463.93M |
|
$-463.93M |
|
$-463.93M |
|
$-463.93M |
|
$-463.93M |
|
$-463.93M |
|
$-569.55M |
|
$-592.40M |
|
122.00M |
|
122.00M |
|
$-3.80 |
|
$-3.80 |
|
| Balance Sheet Financials | |
$1.79B |
|
$198.04M |
|
$1.72B |
|
$3.51B |
|
$140.18M |
|
-- |
|
$65.32M |
|
$205.50M |
|
$3.31B |
|
$3.31B |
|
$3.31B |
|
124.89M |
|
| Cash Flow Statement Financials | |
$-452.63M |
|
$-2.01B |
|
$2.45B |
|
$398.55M |
|
$389.19M |
|
$-9.36M |
|
$84.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-475.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.03% |
|
-14.03% |
|
-13.21% |
|
-14.03% |
|
$26.47 |
|
$-3.89 |
|
|
Operating Cash Flow per Share |
$-3.71 |